StonvexLoading…
StonvexStonvexStonvexCore line items from NVMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $880.58M | $672.40M | $517.92M | $570.73M |
Operating Income | $253.47M | $187.54M | $132.26M | $149.93M |
Net Income | $259.22M | $183.76M | $136.31M | $140.21M |
EPS (Diluted) | $7.96 | $5.75 | $4.28 | $4.43 |
Total Assets | $2.36B | $1.39B | $1.13B | $984.11M |
Total Liabilities | $1.04B | $462.63M | $383.06M | $397.14M |
Cash & Equivalents | $214.46M | $157.78M | $107.57M | $111.12M |
Free Cash Flow OCF − CapEx | $217.91M | $218.05M | $106.34M | $98.22M |
Shares Outstanding | 31.78M | 29.28M | 29.01M | 28.68M |